Correspondence and Assorted Consultancy Papers

Papers largely containing correspondence relating to Marc Feldmann’s consultancy role with Centocor Biotech. The item includes:

Correspondence relating to Centoxin research, research agreements between Centocor and Charing Cross Sunley Research Centre, meeting agendas and anti-TNF research, 1991-1992.

Correspondence relating to Centocor sponsored clinical trials and Marc Feldmann’s general consultancy work with Centocor; papers and correspondence relating to a Centocor collaboration with Osaka University Medical School Japan and Tanabe Seiyaku/ Nippon Centocor KK on a collaboration on anti-TNF or the “CenTNF” program; papers relating to Marc’s attendance at the 8th International Lymphokine Workshop and the 4th International Workshop on Cytokines in Osaka Japan, 1993-1994.

Correspondence relating to Centocor’s transition to being a wholly owned subsidiary of Johnson and Johnson; patent application copies; a copy of Centocor and Kennedy Institute of Rheumatology research and licensing agreement, 1999; clinical trial related correspondence and correspondence relating to anti-TNF royalties, 1998-1999.

Please see reference SA/KET/A/2 for papers relating to the research collaboration between the Kennedy Institute and Centocor Biotech including reference SA/KET/A/2/1 for correspondence between Centocor staff, Ravinder Maini and Marc Feldmann.

1991-2002

1 file (in 3 parts)

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment. This item is also restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2035.